We're delighted to add our latest Educational Series titled: The shifting biologic landscape: exploring ustekinumab in Crohn’s disease. This review presents background information on Crohn’s disease and biologic treatment options available to treat patients with this disease.
The review includes guiding commentary from a panel of doctors lead by Professor Rupert Leong, Senior Staff Specialist, Director of Endoscopy, Head of IBD Services, Concord Hospital, Professor of Medicine, University of Sydney, Sydney Australia.
Please login below to download this issue (PDF)